EP0173921B1 - Verfahren zur Racemisierung einer alpha-Aminocarbonsäure - Google Patents
Verfahren zur Racemisierung einer alpha-Aminocarbonsäure Download PDFInfo
- Publication number
- EP0173921B1 EP0173921B1 EP85110569A EP85110569A EP0173921B1 EP 0173921 B1 EP0173921 B1 EP 0173921B1 EP 85110569 A EP85110569 A EP 85110569A EP 85110569 A EP85110569 A EP 85110569A EP 0173921 B1 EP0173921 B1 EP 0173921B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- amino acid
- dihydroxyphenylglycine
- ketone
- hydroxyphenylglycine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 title 1
- 235000008206 alpha-amino acids Nutrition 0.000 title 1
- 230000006340 racemization Effects 0.000 title 1
- 150000002576 ketones Chemical class 0.000 claims abstract description 25
- 150000007524 organic acids Chemical class 0.000 claims abstract description 17
- ZBWTWPZGSGMRTG-UHFFFAOYSA-N 2-azaniumyl-2-(3,4-dihydroxyphenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(O)C(O)=C1 ZBWTWPZGSGMRTG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000011065 in-situ storage Methods 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims description 26
- LJCWONGJFPCTTL-SSDOTTSWSA-N D-4-hydroxyphenylglycine Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC=C(O)C=C1 LJCWONGJFPCTTL-SSDOTTSWSA-N 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical class C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 40
- 150000001413 amino acids Chemical class 0.000 abstract description 12
- LJCWONGJFPCTTL-ZETCQYMHSA-N L-4-hydroxyphenylglycine Chemical compound OC(=O)[C@@H](N)C1=CC=C(O)C=C1 LJCWONGJFPCTTL-ZETCQYMHSA-N 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 23
- 229960000583 acetic acid Drugs 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000012362 glacial acetic acid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000001632 sodium acetate Substances 0.000 description 7
- 235000017281 sodium acetate Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 6
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- XUJHKPSBHDQIOD-UHFFFAOYSA-N (2-bromo-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)C(Br)C1C2(C)C XUJHKPSBHDQIOD-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000001117 sulphuric acid Substances 0.000 description 5
- 235000011149 sulphuric acid Nutrition 0.000 description 5
- 238000007792 addition Methods 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- -1 phosphoric acid tri-esters Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- LJCWONGJFPCTTL-UHFFFAOYSA-N 4-hydroxyphenylglycine Chemical class OC(=O)C(N)C1=CC=C(O)C=C1 LJCWONGJFPCTTL-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RXSPMCUQMQOINZ-UHFFFAOYSA-N 2-(3,4-dihydroxyanilino)acetic acid Chemical class OC(=O)CNC1=CC=C(O)C(O)=C1 RXSPMCUQMQOINZ-UHFFFAOYSA-N 0.000 description 1
- BHCVMGOCEULNSE-UHFFFAOYSA-N 2-amino-2-(3,4-dihydroxyphenyl)acetic acid;hydrate Chemical compound O.OC(=O)C(N)C1=CC=C(O)C(O)=C1 BHCVMGOCEULNSE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- WPDRUQNZVGNSDN-UHFFFAOYSA-N BrC1C(C2(CCC1C2(C)C)CS(=O)(=O)O)=O.OC2=CC=C(C(N)C(=O)O)C=C2 Chemical compound BrC1C(C2(CCC1C2(C)C)CS(=O)(=O)O)=O.OC2=CC=C(C(N)C(=O)O)C=C2 WPDRUQNZVGNSDN-UHFFFAOYSA-N 0.000 description 1
- MZDWDDVIUSBJAQ-UHFFFAOYSA-N BrC1C(C2(CCC1C2(C)C)CS(=O)(=O)O)=O.OC=2C=C(C(N)C(=O)O)C=CC2O Chemical compound BrC1C(C2(CCC1C2(C)C)CS(=O)(=O)O)=O.OC=2C=C(C(N)C(=O)O)C=CC2O MZDWDDVIUSBJAQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- WRUZLCLJULHLEY-UHFFFAOYSA-N N-(p-hydroxyphenyl)glycine Chemical class OC(=O)CNC1=CC=C(O)C=C1 WRUZLCLJULHLEY-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B55/00—Racemisation; Complete or partial inversion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
Definitions
- This invention relates to a chemical process for the racemisation of a-amino acids.
- Optically active a-amino acids are useful in the synthesis of many physiologically active compounds, in particular as side-chains in penicillin and cephalorsporin antibiotics. It is convenient to synthesize a-amino acids in the racemic form and then resolve into the separate enantiomers. However, in most cases, only one enantiomer has commercial utility and it is therefore desirable to racemise the unwanted isomer, so that the racemate produced may again be subjected to resolution.
- British Patent 1,432,822 describes the racemisation of an ester of an amino acid by the use of an aldehyde or ketone.
- British Patent 1,417,060 describes the racemisation of an N-acyl amino acid by heating in a solvent selected from phosphoric acid tri-esters, lower fatty acids containing up to 4 carbon atoms, dialkylformamides, ketones and dialkylsulphoxides.
- British Patent 1,560,907 describes the racemisation of an amide of an amino acid by heating in solvent in the presence of a ketone and an acid having a dissociation constant below 1.8x 10- 4 .
- Japanese patent application 1512/78 (Kokai 54-109912) describes the racemisation of an ester of an amino acid by heating in the presence of a ketone and a protonic or Lewis acid.
- European patent specification No. 57092 describes the racemisation of an amino acid itself or a salt thereof in the presence of an aliphatic acid and an aldehyde.
- German patent 1 543 919 describes a process for the racemisation of an optically active amino acid by treatment with an a-ketocarboxylic acid and metal ions at 50-110°.
- Japanese patent application (Kokai 52-71 440) describes a conventional resolution of DL-p-hydroxyphenylglycine by treatment with optically active bromocamphor sulphonic acid to give diastereoisomeric salts which are then separated by solubility differences.
- the present invention relates to the racemisation of free amino acids by the use of a ketone in the presence of an organic acid.
- the above prior art teaches away from such a process.
- the present invention provides a process for racemisation of an a-amino acid or salt thereof which comprises treating an optically active a-amino acid of formula (I). wherein R represents phenyl optionally substituted with up to three groups selected from hydroxy or halogen, characterised in that the a-amino acid of formula I or salt thereof is treated with a ketone in the presence of an organic acid.
- Suitable a-amino acids of formula (I) include phenylglycine, mono- and di-hydroxyphenyl glycines. Particularly preferred a-amino acids of formula (I) are 4-hydroxyphenyl glycine and 3,4-dihydroxyphenylglycine.
- the a-amino acid may be employed in the form of the acid itself or a salt thereof.
- Suitable salts of the a-amino acid include acid salts, basic salts, internal zwitterionic salts and acid addition salts.
- alkali metal salts such as sodium
- acid addition salts such as acetate or benzoate.
- salts which have been used in the resolution of the a-amino acid such as bromocamphor sulphonate salts.
- Ketones which are suitable for the process of the invention may have the formula II: wherein R' and R 2 may be the same or different and each represents a hydrocarbon or heterocyclic group, as defined above, or R' and R 2 together complete a cycloalkanone ring.
- ketones include acetone, methylethylketone, methylisobutylketone, cyclohexanone and cyclopetanone.
- the ketone may be employed in excess. Conveniently the quantity of ketone employed is from 2% to 50% of the total solvent volume, i.e. 0.5 to 20 mole, preferably 1 to 10 mole per mole of a-amino acid.
- Organic acids which are suitable for the process of the invention include C l - 6 alkanoic acids, for example formic acid, acetic acid, propionic acid and butyric acid.
- a preferred organic acid is acetic acid. It is preferred to use from 5 to 50 moles of organic acid per mole of amino acid.
- the organic acid, together with the ketone, may conveniently form the solvent for the racemisation process.
- the ketone and the organic acid employed in the process may conveniently be used as the solvent in the racemisation reaction. Additional co-solvents may, however, also be employed.
- racemic amino acid may be recovered by conventional methods, for example by crystallisation.
- Processes of the present invention are normally carried out at temperatures of 60°C or more, preferably 80°C or more. Most preferred are reactions carried out under reflux. Thus where acetic acid is used as the organic acid, the reaction is carried out at 115-120°C at atmospheric pressure or at about 70°C under vacuum.
- the advantage of the process of the present invention is to provide a racemic a-amino acid which can be subjected to resolution in order to obtain further quantities of the desired enantiomer.
- the racemisation process is carried out in the same solution as a resolution process, so that the unwanted isomer is racemised in situ while the desired isomer is continuously removed from solution by the resolving agent.
- the present invention provides a process for the preparation of an optically active a-amino acid, which process comprises resolving a racemic a-amino acid in the presence of a ketone and an organic acid.
- resolving agent will depend, of course, on the particular amino acid.
- phenylglycine may be resolved using camphor-10-sulphonic acid; 4-hydroxyphenylglycine is conveniently resolved by using diastereoisomeric salts with 3-bromocamphor-9-sulphonic acid (which is also referred to as 3-bromocamphor-8-sulphonic acid-see Japanese application No. 50-148144; Kokai 52-71440).
- European patent application 85106310.7 discloses the resolution of 3,4 dihydroxyphenylglycine by using diastereoisomeric salts with 3-bromocamphor-9-sulphonic acid.
- the present invention provides a process for the preparation of optically active 4-hydroxyphenylglycine or 3,4-dihydroxyphenylglycine, which process comprises allowing a 3-bromocamphor-9-sulphonate salt thereof to crystallise from a solution of a mixture of diastereoisomeric camphorsulphonate salts of a 4-hydroxyphenyglycine or 3,4 dihydroxyphenylglycine, in the presence of a ketone and an organic acid; and liberating said optically active 4-hydroxyphenylglycine or 3,4-dihydroxyphenylglycine.
- the diastereoisomeric bromocamphorsulphonate salts are separated by preferential crystallisation.
- the crystallisation may need to be induced by concentration of the solution, by adding a further solvent in which one diastereoisomer is less soluble, such as water; or by seed crystals of the desired diastereoisomer.
- a further solvent in which one diastereoisomer is less soluble such as water
- seed crystals of the desired diastereoisomer Such seeding may be particuiariy desirable for the salts of D-3,4-dihydroxyphenylglycine.
- Suitable bases are those which are capable of liberating the 4-hydroxyphenylglycine or 3,4 dihydroxyphenylglycine from the diastereoisomeric camphor sulphonate salt or, for example, bases which are stronger than the 4-hydroxyphenylglycine or 3,4 dihydroxyphenylglycine, such as sodium acetate, potassium acetate, sodium hydroxide and potassium hydroxide.
- This salt-splitting reaction may, surprisingly, be carried out in virtually the same solvent system as the resolution and racemisation, normally the ketone and organic acid and in particular acetic acid, thus providing a significant advantage for the process of the invention over the prior art processes.
- the presence of a little water, for example 5-10% is desirable to prevent racemisation occurring. This water is readily removed subsequently.
- a further advantage for the process of the invention is the resistance of ketones to degradation.
- the process of the present invention can be operated more than 10 times in the same solvent without excessive ketone degradation.
- the ketone may be used as the solvent for this extraction.
- L(+)-4-hydroxyphenylglycine-3-bromocamphor-9-sulphonate (L(+)HSC) was heated at 90°C together with 0.03 g sodium acetate, 13.3 ml glacial acetic acid, and 6.6 ml methyl isobutyl ketone for 48 hours.
- Hplc analysis showed that conversion to D(-)-4-hydroxyphenylglycine 3-bromocamphor-9-sulphonate (D(-)HSC) was in excess of 99%.
- D(-) 3,4-dihydroxyphenylglycine bromocamphorsulphonate was prepared by adding 275 ml 2N sulphuric acid to a suspension of D(-)-3,4-dihydroxyphenylglycine (50 g) and ammonium bromocamphor-9-sulphonate (90 g) in water (100 ml). After thorough drying 9.5 g of the above salt was mixed with glacial acetic acid (100 ml), butanone (50 ml), and sodium acetate (0.3 g). The mixture was stirred and refluxed for one hour at which point it consisted of a clear orange solution.
- Racemic 3,4-dihydroxyphenylglycine monohydrate (52 g, assay 88.47%) was added and stirred vigorously.
- the amino acid went briefly into solution then crystallised as the bromocamphor-9-sulphonate salt. After half an hour this was filtered, washed with a minimum of glacial acetic acid and then butanone, dried and assayed. The procedure was repeated with two further additions of 20 g racemic acid.
- the third crop appeared to be a mixture (by IR spectrum) so an equivalence point had evidently been reached.
- a further small quantity of salt was obtained on standing at room temperature. Crops 1, 2 and 4 represent a conventional resolution with a yield of salt of about 42% (uncorrected for purity).
- Toluene (100 ml) and sodium acetate (0.5 g) were added to the combined filtrate and washings and the solution refluxed gently with a cooled Dean and Stark head to remove a water rich lower phase.
- Crops 1, 2, 4, 5 and 6 were suspended in 250 ml H 2 0 and treated with 50% aqueous NaOH to pH 4.5. After 1 hour stirring the product was filtered, washed with water, and dried.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT85110569T ATE34381T1 (de) | 1984-08-30 | 1985-08-22 | Verfahren zur racemisierung einer alphaaminocarbons|ure. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8421964 | 1984-08-30 | ||
GB848421964A GB8421964D0 (en) | 1984-08-30 | 1984-08-30 | Chemical process |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0173921A1 EP0173921A1 (de) | 1986-03-12 |
EP0173921B1 true EP0173921B1 (de) | 1988-05-18 |
Family
ID=10566049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP85110569A Expired EP0173921B1 (de) | 1984-08-30 | 1985-08-22 | Verfahren zur Racemisierung einer alpha-Aminocarbonsäure |
Country Status (12)
Country | Link |
---|---|
US (1) | US4647692A (de) |
EP (1) | EP0173921B1 (de) |
JP (1) | JPS6169748A (de) |
AT (1) | ATE34381T1 (de) |
AU (1) | AU4682585A (de) |
DE (1) | DE3562772D1 (de) |
DK (1) | DK391585A (de) |
ES (1) | ES8703827A1 (de) |
GB (1) | GB8421964D0 (de) |
GR (1) | GR852076B (de) |
PT (1) | PT81043B (de) |
ZA (1) | ZA856540B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499376A1 (de) * | 1991-01-31 | 1992-08-19 | Hoechst Celanese Corporation | Asymmetrische Umwandlung von chirales Aminosäure und ihre Salze durch Fällung |
DE4407197A1 (de) * | 1994-03-04 | 1995-09-07 | Hoechst Schering Agrevo Gmbh | Verfahren zur Herstellung von /L/-Homoalanin-4-yl-(methyl)phosphinsäure und deren Salze durch Racematspaltung |
WO1996011173A2 (en) * | 1994-10-07 | 1996-04-18 | Chiroscience Limited | Racemisation of precursors to levobupivacaine and analogues thereof |
US6156900A (en) * | 1994-10-07 | 2000-12-05 | Darwin Discovery Limited | Racemization of precursors to levobupivacaine and analogues thereof |
US6812363B2 (en) * | 2002-10-15 | 2004-11-02 | Usv Limited | Racemization of optically active 2-substituted phenyl glycine esters |
JP2011024572A (ja) * | 2009-06-29 | 2011-02-10 | Mitsubishi Gas Chemical Co Inc | 光学活性アミノ酸の製造法 |
KR20170029965A (ko) * | 2015-09-08 | 2017-03-16 | 주식회사 아미노로직스 | D-아르기닌의 제조 방법 |
WO2018108794A1 (de) | 2016-12-15 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Verfahren zur herstellung von d-glufosinat oder dessen salzen unter verwendung von ephedrin |
WO2018108797A1 (de) | 2016-12-15 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Verfahren zur herstellung von l-glufosinat oder dessen salzen unter verwendung von ephedrin |
CA3133296A1 (en) | 2019-04-16 | 2020-10-22 | Brian Michael GREEN | Methods for producing crystalline l-glufosinate ammonium monohydrate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3458568A (en) * | 1965-02-19 | 1969-07-29 | Toa Gosei Chem Ind | Process for preparing an optically inactive amino acid from an optically active amino acid |
GB1417060A (en) * | 1972-10-19 | 1975-12-10 | Ajinomoto Kk | Racemization of optically active n-acyl amino acids |
JPS54109912A (en) * | 1978-02-14 | 1979-08-29 | Ajinomoto Co Inc | Racemization of optically active amino acid ester |
US4401820A (en) * | 1981-01-23 | 1983-08-30 | Tanabe Seiyaku Co., Ltd. | Process for racemizing optically active α-amino acids or a salt thereof |
JPS5810544A (ja) * | 1981-07-09 | 1983-01-21 | Tanabe Seiyaku Co Ltd | 光学活性p−ヒドロキシフエニルグリシン塩の製法 |
-
1984
- 1984-08-30 GB GB848421964A patent/GB8421964D0/en active Pending
-
1985
- 1985-08-22 DE DE8585110569T patent/DE3562772D1/de not_active Expired
- 1985-08-22 EP EP85110569A patent/EP0173921B1/de not_active Expired
- 1985-08-22 AT AT85110569T patent/ATE34381T1/de not_active IP Right Cessation
- 1985-08-28 JP JP60189331A patent/JPS6169748A/ja active Pending
- 1985-08-28 GR GR852076A patent/GR852076B/el unknown
- 1985-08-28 DK DK391585A patent/DK391585A/da not_active Application Discontinuation
- 1985-08-28 US US06/770,508 patent/US4647692A/en not_active Expired - Fee Related
- 1985-08-28 AU AU46825/85A patent/AU4682585A/en not_active Abandoned
- 1985-08-28 PT PT81043A patent/PT81043B/pt unknown
- 1985-08-28 ES ES546489A patent/ES8703827A1/es not_active Expired
- 1985-08-28 ZA ZA856540A patent/ZA856540B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GR852076B (de) | 1985-12-23 |
PT81043B (en) | 1987-04-06 |
ZA856540B (en) | 1986-06-25 |
ES8703827A1 (es) | 1987-03-01 |
DK391585D0 (da) | 1985-08-28 |
DE3562772D1 (en) | 1988-06-23 |
EP0173921A1 (de) | 1986-03-12 |
AU4682585A (en) | 1986-03-06 |
DK391585A (da) | 1986-03-01 |
US4647692A (en) | 1987-03-03 |
PT81043A (en) | 1985-09-01 |
ATE34381T1 (de) | 1988-06-15 |
ES546489A0 (es) | 1987-03-01 |
JPS6169748A (ja) | 1986-04-10 |
GB8421964D0 (en) | 1984-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0462776B1 (de) | Herstellung von optisch aktiven arylaliphatischen Carbonsäuren | |
CZ374297A3 (cs) | Způsoby přípravy kyseliny (S)-3-(aminomethyl)-5-methylhexanové | |
EP0173921B1 (de) | Verfahren zur Racemisierung einer alpha-Aminocarbonsäure | |
EP0325965B1 (de) | Verfahren zur optischen Spaltung einer rakemischen Säure | |
US5235100A (en) | Preparation of optically active aliphatic carboxylic acids | |
JP2009120611A (ja) | エナンチオマーとして純粋なアゼチジン−2−カルボン酸の改良された製造方法 | |
JPH0219339A (ja) | 2−(6−メトキシ−2−ナフチル)プロピオン酸の光学分割方法 | |
US4319040A (en) | Process for the production of optically active threo-3-(3,4-dihydroxyphenyl)serine | |
EP0075318B1 (de) | P-Hydroxyphenylglycin-Alpha-Phenylethansulfonat, Verfahren zu dessen Herstellung und Verwendung in der Spaltung von P-Hydroxyphenylglycin | |
US4172846A (en) | Process for separating a mixture of an optically active phenylglycine amide and an optically active phenylglycine | |
US5235095A (en) | Preparation of optically active aliphatic carboxylic acids | |
US4183865A (en) | Process for the resolution of racemic α-aminonitriles | |
EP0070114B1 (de) | Verfahren zur Herstellung von optisch aktivem p-Hydroxyphenylglycin oder Salz daraus | |
EP0805793B1 (de) | Herstellung von optisch aktiven aliphetischen carbonsäuren | |
US5292933A (en) | Process for the resolution of threo-3-[(2-aminophenyl)-thio]-2-hydroxy-3-(4-methoxy-phenyl)propionic acid | |
US4233456A (en) | Process for the manufacture of optically active, optionally substituted 2-amino-2-phenylacetic acid | |
EP0382506B1 (de) | Optisch aktive Diastereoisomersalze von Tetrahydro-2-furancarbonsäure | |
JPH0859517A (ja) | 光学分割剤およびそれを用いた光学活性テトラヒドロフランカルボン酸類の製造法 | |
WO1985003932A1 (en) | Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof | |
WO2006053440A1 (en) | New processes for the preparation of optically pure indoline-2-carboxylic acid and n-acetyl-indoline-2-carboxylic acid | |
EP0253571B1 (de) | Verfahren zur Trennung und Racemisierung von Aminen mit sauren alpha-Wasserstoffen | |
PH26254A (en) | Optically active-oxo-isoindolinyl derivatives | |
US7078533B2 (en) | Method for the racemization of etodolic acid | |
EP0001821B1 (de) | Verfahren zur Racematspaltung von DL-alpha-Aminocarbonsäuren und dafür verwendete Salze | |
US5977391A (en) | (+)- and (-) -8-halogen-6- hydroxy-octanoic acid its salts and esters and process for making |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19860410 |
|
17Q | First examination report despatched |
Effective date: 19861002 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Effective date: 19880518 |
|
REF | Corresponds to: |
Ref document number: 34381 Country of ref document: AT Date of ref document: 19880615 Kind code of ref document: T |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19880531 |
|
REF | Corresponds to: |
Ref document number: 3562772 Country of ref document: DE Date of ref document: 19880623 |
|
ET | Fr: translation filed | ||
ITF | It: translation for a ep patent filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19880831 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19890822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19890831 Ref country code: CH Effective date: 19890831 Ref country code: BE Effective date: 19890831 |
|
BERE | Be: lapsed |
Owner name: BEECHAM GROUP P.L.C. Effective date: 19890831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19900301 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19900427 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19900501 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |